Event

Schedule a meeting with our scientific experts during DCAT Week.

Schedule a meeting

Events

Solubilizing the insoluble - Royal Society of Chemistry Event

2 December 2021

Join Quotient's Vice President of Integrated Services, Dr Asma Patel for her talk at the virtual "Solubilizing the insoluble - Formulation approaches" event on December 2nd.  This event is being hosted by the Formulation Science and Technology Group (FSTG), a subject interest group of the Royal Society of Chemistry (RSC).

Presentation Overview:

Title: Accelerated development strategies for poorly soluble molecules

Description: Improving solubility remains one of the greatest barriers to successful drug delivery. Biotech and pharma development teams are constantly under pressure to rapidly advance molecules to the next development milestone and get to market as quickly as possible. However, progress is often constrained by formulation challenges in early stage drug development, with the prevalence of poorly soluble compounds within the development pipeline, being a prime example. 

Join Quotient's Vice President of Integrated Development Services, Dr Asma Patel, as she shares expert insight and case studies on formulation and solubility challenges and discuss the best strategies and technologies for advancing poorly soluble molecules, to deliver success.

Key Learning Objectives:

-Pharmaceutics and biopharmaceutics profiling of NCEs
-The DCS classification system as a foundation for creating a formulation development roadmap
-Formulation strategies for DCS Class IIb compounds
-A review of the formulation technologies available from size-reduction, to lipid systems and amorphous forms
-Selecting appropriate biorelevant in vitro characterization methods to inform potential clinical performance
-Choosing the right formulation for preclinical studies and dosage forms for First-in-Human (FIH) studies

Event Details:

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.